Javascript must be enabled to continue!
Deanol, Lithium and Placebo in the Treatment of Tardive Dyskinesia
View through CrossRef
A double-blind crossover study on the effects of deanol and lithium carbonate was conducted on a sample of 29 chronic schizophrenic patients with tardive dyskinesia. In addition to his usual treatment with different neuroleptics, each patient received during an 8-week period either deanol, lithium carbonate or placebo. A 4-week wash-out period was inserted between each of the 8-week periods of experimental treatment of the tardive dyskinesia. The administration of either deanol, lithium carbonate or placebo added to the neuroleptic treatment did not produce a statistically significant improvement of tardive dyskinesia in our patient population as a whole. Favorable and unfavorable responses are discussed.
Title: Deanol, Lithium and Placebo in the Treatment of Tardive Dyskinesia
Description:
A double-blind crossover study on the effects of deanol and lithium carbonate was conducted on a sample of 29 chronic schizophrenic patients with tardive dyskinesia.
In addition to his usual treatment with different neuroleptics, each patient received during an 8-week period either deanol, lithium carbonate or placebo.
A 4-week wash-out period was inserted between each of the 8-week periods of experimental treatment of the tardive dyskinesia.
The administration of either deanol, lithium carbonate or placebo added to the neuroleptic treatment did not produce a statistically significant improvement of tardive dyskinesia in our patient population as a whole.
Favorable and unfavorable responses are discussed.
Related Results
Study of possible radioprotective properties of deanol aceglumate under the action of ionizing radiation on human cells
Study of possible radioprotective properties of deanol aceglumate under the action of ionizing radiation on human cells
One of the effective methods to mitigate late side effects of radiotherapy is to use radioprotectors that reduce harmful effects of ionizing radiation on living cells. Nowadays the...
Safety and Efficacy of Atezolizumab in Ovarian Cancer
Safety and Efficacy of Atezolizumab in Ovarian Cancer
Abstract
Introduction
Although the efficacy of PD-L1 blockade has been evaluated in analyses that combine pharmacologically distinct antibodies, the specific efficacy and safety of...
Tardive dyskinesia and impaired glucose tolerance
Tardive dyskinesia and impaired glucose tolerance
AbstractThe authors examined the role of impaired glucose metabolism in the pathophysiology of tardive dyskinesia in schizophrenic patients with and without persistent TD. Glucose ...
Antipsychotic Drug Induced Tardive Dyskinesia
Antipsychotic Drug Induced Tardive Dyskinesia
A typical antipsychotics are at a lower risk of developing extra-pyramidal symptoms (EPS). But now, atypical antipsychotics are increasingly being associated with neurological side...
Bereitschaftspotential in tardive dyskinesia
Bereitschaftspotential in tardive dyskinesia
AbstractThe bereitschaftspotential or motor readiness potential is a slow negative electroencephalographic wave occurring 150–1500 ms prior to the onset of a voluntary movement. It...
Lithium Prospectivity in the Northeast German and Thuringian Ba-sins
Lithium Prospectivity in the Northeast German and Thuringian Ba-sins
Over the years many boreholes have been drilled into the Northeast German Basin (NEGB) in pursuit of the exploration of hydrocarbons. As well as gaining important information regar...
Association of Breast-Feeding Positions with Scapular Dyskinesia in Postpartum Females
Association of Breast-Feeding Positions with Scapular Dyskinesia in Postpartum Females
Background: Breastfeeding is a vital activity for the nurturing and development of infants. However, the postures adopted during breastfeeding may have implications for the physica...
Elevated Cerebrospinal Fluid Noradrenaline in Tardive Dyskinesia
Elevated Cerebrospinal Fluid Noradrenaline in Tardive Dyskinesia
SummaryCerebrospinal fluid was collected from 28 psychiatric (mostly schizophrenic) inpatients from Bombay, India. These included eight patients with tardive dyskinesia, five with ...

